What Is a Cancer Stage?

 

Following a diagnosis of cancer, the most important step is to accurately determine the stage of the cancer. The stage describes how far the cancer has spread. (Some cancers, such as leukemia, are not staged.) Each stage of cancer may be treated differently.

To begin evaluating and discussing treatment options with your health care team, you need to know the stage of your cancer.

There are many staging systems, but the TNM system is the most common. This system uses three different codes to describe the size and location of the tumor, whether it has spread to the lymph nodes around the tumor, and whether it can be found in other parts of the body. Specifically, “T” refers to the size and location of the tumor, “N” to the number of lymph nodes (tiny bean-shaped organs throughout the body that help fight infection) involved, and “M” to whether the cancer has spread (metastasized) to other parts of the body.

After the T, N, and M categories of your cancer have been identified, your doctor will combine this information to assign a stage (0 to IV) to your cancer. The higher the number, the more serious (advanced) the cancer is.

  • Stage 0 - precancer
  • Stage I - small cancer found only in the site where it started
  • Stage II - larger cancer that may have spread to the lymph nodes
  • Stage III - larger cancer that is also in the lymph nodes and possibly in nearby organs
  • Stage IV - cancer that has spread to a different part of the body from where it started
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health